Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma
Agustín Avilés, Natividad Neri, J Fernández-Díez, et al.
Hematology (2015) Vol. 20, Iss. 9, pp. 538-542
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
European Journal of Cancer (2017) Vol. 77, pp. 57-74
Open Access | Times Cited: 420
Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3483-3483
Open Access | Times Cited: 241
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 132
The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils
Ekaterina Pylaeva, Stephan Lang, Jadwiga Jabłońska
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 99
Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma
Sadanori Furudate, Taku Fujimura, Aya Kakizaki, et al.
Journal of Dermatological Science (2016) Vol. 83, Iss. 3, pp. 182-189
Closed Access | Times Cited: 51
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
Daniel Heudobler, Michael Rechenmacher, Florian Lüke, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3540-3540
Open Access | Times Cited: 48
Therapeutic Antibodies in Cancer Therapy
Martin Gasser, Ana Maria Waaga-Gasser
Advances in experimental medicine and biology (2016), pp. 95-120
Closed Access | Times Cited: 41
Interventions for mycosis fungoides
Arash Valipour, Manuel Jäger, Peggy A. Wu, et al.
Cochrane library (2020) Vol. 2020, Iss. 7
Open Access | Times Cited: 29
Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic
Rudolf Stadler, Julia Scarisbrick
European Journal of Cancer (2020) Vol. 142, pp. 38-47
Closed Access | Times Cited: 25
STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia
Shella Saint Fleur-Lominy, Máté Maus, Martin Vaeth, et al.
Cell Reports (2018) Vol. 24, Iss. 11, pp. 3045-3060.e5
Open Access | Times Cited: 27
Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials
Shuting Chen, Qinchao Hu, Xiaoan Tao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
Daniel Heudobler, Michael Rechenmacher, Florian Lüke, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 22
<p>Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel</p>
Dennis Denis, N. Bénéton, Kamel Laribi, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 2241-2251
Open Access | Times Cited: 22
Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome
Madeleine Duvic
Hematology (2015) Vol. 2015, Iss. 1, pp. 529-544
Open Access | Times Cited: 17
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
Diagnosing liver fibrosis: a narrative review of current literature for dermatologists
Jonathan R. Potts, Catriona Maybury, Amr Salam, et al.
British Journal of Dermatology (2016) Vol. 177, Iss. 3, pp. 637-644
Closed Access | Times Cited: 12
Polyphenolic drug composition based on benzenepolycarboxylic acids (BP-C3) increases life span and inhibits spontaneous tumorigenesis in female SHR mice
Vladimir N. Anisimov, Irina G. Popovich, Mark A. Zabezhinski, et al.
Aging (2016) Vol. 8, Iss. 9, pp. 1866-1875
Open Access | Times Cited: 11
The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review
Mehul Dalal, Stephen Mitchell, Conor McCloskey, et al.
Expert Review of Hematology (2020) Vol. 13, Iss. 4, pp. 405-419
Open Access | Times Cited: 11
Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome
Faraj K. Alenezi, Catherine Girard, D. Bessis, et al.
Acta Dermato Venereologica (2020) Vol. 101, Iss. 2, pp. adv00384-adv00384
Open Access | Times Cited: 9
Monoclonal antibodies against cutaneous T-cell lymphomas
Mauro Alaibac
Expert Opinion on Biological Therapy (2017) Vol. 17, Iss. 12, pp. 1503-1510
Closed Access | Times Cited: 6
Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate
Vassiliki Mpakou, Evangelia Papadavid, Frieda Kontsioti, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0170186-e0170186
Open Access | Times Cited: 5
Therapeutic Antibodies in Cancer Therapy
Martin Gasser, Ana Maria Waaga-Gasser
Springer eBooks (2015), pp. 95-120
Closed Access | Times Cited: 3
Immunobiology and treatment of cutaneous T-cell lymphoma
Rishi R. Goel, Alain H. Rook
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 985-996
Closed Access
Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study
Vasiliki Nikolaou, Evdoxia Panou, Antonios Tsimpidakis, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access
Page 1 - Next Page

Scroll to top